Product Name: Ticagrelor CAS 274693-27-5
Chemical & Physical Properties:
Appearance : White to Off-White powder
Assay : ≥99.0%
Melting point: N/A
Boiling Point: 777.551℃ at 760 mmHg
Flash Point: 424.048℃
Refractive Index: 1.744
Solubility: Methanol (Slightly)
Category: Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds
HS Code: 2933990090
Safety Statements: R26-36/37/39
Risk Statements: S36/37/38
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application: 1. Ticagrelor (AZD6140) is a reversible oral P2Y12 receptor antagonist for the treatment of platelet aggregation.
2. Ticagrelor (trade name Brilinta, Brilique, and Possia) is a platelet aggregation inhibitor produced by AstraZeneca.
3. Ticagrel is used to reduce cardiovascular death and heart attack in patients with acute coronary syndrome (ACS).
Our factory manufacture’s Ticagrelor CAS 274693-27-5, mature technology, stable output, quality assurance.
Inventory Status : In Stock.
We can provide Ticagrelor CAS 274693-27-5 certificate of analysis( COA), (1S,2S,3R,5S)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl)aMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol MOA, Ticagrelor CAS 274693-27-5 ROS, (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol MSDS and other support for you!
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.